Associate Professor
Endocrinology
Dr. Thomas J. Baranski, MD
|
|
Give Review
Thomas Baranski works in the field of Endocrinology. He went to Washington University School of Medicine in St. Louis. He received awards:"CMS Meaningful Use Stage 1 Certification" and "Elected Member". Dr. Thomas J. Baranski is a published MD. He has 47 publications published. The most current publication "A Gsalpha mutant designed to inhibit receptor signaling through Gs."
Publications
- BRAF mutation is not predictive of long-term outcome in papillary Thyroid carcinoma.
- Transformed Drosophila Cells Evade Diet-Mediated Insulin Resistance through Wingless Signaling.
- Evidence for transgenerational metabolic programming in Drosophila.
- Frizzled receptors signal through G proteins.
- Role of fat body lipogenesis in protection against the effects of caloric overload in Drosophila.
- A Drosophila model of high sugar diet-induced cardiomyopathy.
- Structural mechanisms of constitutive activation in the C5a receptors With mutations in the extracellular loops: Molecular modeling study.
- Difference between restoring and predicting 3D structures of the loops in G-protein-coupled receptors by molecular modeling.
- A high-sugar diet produces obesity and insulin resistance in wild-Type Drosophila.
- Simplified modeling approach suggests structural mechanisms for constitutive activation of the C5a receptor.
- Thyroid cancer: what to do AFTER fine needle aspiration.
- Third extracellular loop (EC3)-N terminus interaction is important for seven-transmembrane domain receptor function: implications for an activation microswitch region.
- Electron paramagnetic resonance studies of functionally active, nitroxide spin-labeled peptide analogues of the C-terminus of a G-protein alpha subunit.
- Modeling the possible conformations of the extracellular loops in G-protein-coupled receptors.
- Computational modeling of constitutively active mutants of GPCRs C5a receptor.
- Structural models for the complex of chemotaxis inhibitory protein of Staphylococcus aureus With the C5a receptor.
- Prognostic factors in patients With well-differentiated thyroid cancer presenting With pulmonary metastasis.
- Structure of the complement factor 5a receptor-ligand complex studied by disulfide trapping and molecular modeling.
- Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor.
- Beta2-chimaerin in Cancer signaling: connecting cell adhesion and MAP kinase activation.
- Chimaerin and Rac regulate cell number, adherens junctions, and ERK MAP kinase signaling in the Drosophila eye.
- A comprehensive structure-function map of the intracellular surface of the human C5a receptor. II. Elucidation of G protein specificity determinants.
- A comprehensive structure-function map of the intracellular surface of the human C5a receptor. I. Identification of critical residues.
- Random mutagenesis of the complement factor 5a (C5a) receptor N terminus provides a structural constraint for C5a docking.
- Genetic analysis of the first and third extracellular loops of the C5a receptor reveals an essential WXFG motif in the first loop.
- Motion of carboxyl terminus of Galpha is restricted upon G protein activation. A solution NMR study using semisynthetic Galpha subunits.
- Essential role for the second extracellular loop in C5a receptor activation.
- C5a receptor oligomerization. II. Fluorescence resonance energy transfer studies of a human G protein-coupled receptor expressed in yeast.
- C5a receptor oligomerization. I. Disulfide trapping reveals oligomers and potential contact surfaces in a G protein-coupled receptor.
- Constitutive activation and endocytosis of the complement factor 5a receptor: evidence for multiple activated conformations of a G protein-coupled receptor.
- An activation switch in the ligand binding pocket of the C5a receptor.
- Functional reconstitution of the angiotensin II Type 2 receptor and G(i) activation.
- Genetic mapping of the human C5a receptor. Identification of transmembrane amino acids critical for receptor function.
- Similar structures and shared switch mechanisms of the beta2-adrenoceptor and the paraThyroid hormone receptor. Zn(II) bridges between helices III and VI block activat...
- C5a receptor activation. Genetic identification of critical residues in four transmembrane helices.
- A Gsalpha mutant designed to inhibit receptor signaling through Gs.
- A novel mutagenesis strategy identifies distantly spaced amino acid sequences that are required for the phosphorylation of both the oligosaccharides of procathepsin D ...
- Generation of a lysosomal enzyme targeting signal in the secretory protein pepsinogen.
- Mapping and molecular modeling of a recognition domain for lysosomal enzyme targeting.
- Lysosomal enzyme phosphorylation. II. Protein recognition determinants in either lobe of procathepsin D are sufficient for phosphorylation of both the amino and carbox...
- Lysosomal enzyme phosphorylation. I. Protein recognition determinants in both lobes of procathepsin D mediate its interaction With UDP-GlcNAc:lysosomal enzyme N-acetyl...
- Expressed protein ligation to study protein interactions: semi-synthesis of the G-protein alpha subunit.
- E2F8 is a nonreceptor activator of heterotrimeric G proteins.
- Conformational movement of F251 contributes to the molecular mechanism of constitutive activation in the C5a receptor.
- Comparison of the retinitis pigmentosa mutations in rhodopsin With a functional map of the C5a receptor.
- Complement factor 5a receptor chimeras reveal the importance of Lipid-facing residues in transport competence.
Schools
Washington Center School of Medicine
Conditions Treated
- Adrenal Insufficiency
- Calcium Metabolism Disorders
- Cushing's Syndrome
- Diabetes Insipidus
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Elected Member
Education
-
UCSF -
Washington University School of Medicine in St. Louis
Hospital
-
Barnes-Jewish Hospital
Drug Facts
| NPI NUMBER | 1710903026 | |
| NPPES Provider LastName | BARANSKI | |
| NPPES Provider FirstName | THOMAS | |
| NPPES Provider ZIPCode | 631101020 | |
| NPPES Provider State | MO | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 530.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1710903026 |
| Last Name Of The Provider | BARANSKI |
| First Name Of The Provider | THOMAS |
| View All |
Similar Doctors
|
|
Dr. Farid Roman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Naman A. Ghazal-Albar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bithika M. Thompson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicole M. Ducharme, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip E. Cryer, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Amy E. Riek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ruenrudee Suwannasri, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Veronica P. McGregor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amin A. Radparvar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James R. Etzkorn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janet B. McGill, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. K G. Thampy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prajesh M. Joshi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sina A. Jasim, MD
This Doctor is OpenDoctor Recommended.
|